These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29569949)

  • 1. Altered expression of transcription factors IRF4 and IRF8 in peripheral blood B cells is associated with clinical severity and circulating plasma cells frequency in patients with myasthenia gravis.
    Zhang Y; Jia X; Xia Y; Li H; Chen F; Zhu J; Zhang X; Zhang Y; Wang Y; Xu Y; Pan M; Huang X; Yu T; Fu L; Xiao C; Geng D
    Autoimmunity; 2018 May; 51(3):126-134. PubMed ID: 29569949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD19+ Tim-1+ B cells are decreased and negatively correlated with disease severity in Myasthenia Gravis patients.
    Zhang Y; Zhang X; Xia Y; Jia X; Li H; Zhang Y; Shao Z; Xin N; Guo M; Chen J; Zheng S; Wang Y; Fu L; Xiao C; Geng D; Liu Y; Cui G; Dong R; Huang X; Yu T
    Immunol Res; 2016 Dec; 64(5-6):1216-1224. PubMed ID: 27677768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
    Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
    Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X
    Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting outcome in ocular myasthenia gravis.
    Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
    Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.
    Feng X; Huan X; Yan C; Song J; Lu J; Zhou L; Wu H; Qiao K; Lu J; Xi J; Luo S; Zhao C
    Eur Neurol; 2020; 83(2):182-188. PubMed ID: 32526733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative modifications of blood serum proteins in myasthenia gravis.
    Adamczyk-Sowa M; Bieszczad-Bedrejczuk E; Galiniak S; Rozmiłowska I; Czyżewski D; Bartosz G; Sadowska-Bartosz I
    J Neuroimmunol; 2017 Apr; 305():145-153. PubMed ID: 28284335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-21 enhances STAT3/Blimp-1 signaling pathway in B cells and contributes to plasma cell differentiation in newly diagnosed patients with myasthenia gravis.
    Xu Y; Huang X; Li F; Liu T; Yang T; Chen F; Zhu J; Pan M; Zhang Y; Wang Y; Fu L; Xiao C; Geng D
    Immunol Res; 2021 Feb; 69(1):59-70. PubMed ID: 33145710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The increased expression of CD21 on AchR specified B cells in patients with myasthenia gravis.
    Yin W; Allman W; Ouyang S; Li Y; Li J; Christadoss P; Yang H
    J Neuroimmunol; 2013 Mar; 256(1-2):49-54. PubMed ID: 23266128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody.
    Apinyawasisuk S; Chongpison Y; Thitisaksakul C; Jariyakosol S
    Am J Ophthalmol; 2020 Jan; 209():10-17. PubMed ID: 31562855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of circulating Aire and increased Tfh/Tfr cells in myasthenia gravis patients.
    Zhao S; Ding J; Wang S; Li C; Guo P; Zhang M; Li Z
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29773681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequencies of circulating Tfh-Th17 cells in myasthenia gravis patients.
    Yang Y; Zhang M; Ye Y; Ma S; Fan L; Li Z
    Neurol Sci; 2017 Sep; 38(9):1599-1608. PubMed ID: 28578482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of IL-21 in the peripheral blood of myasthenia gravis patients and its correlation with anti-AChR-Ab class switch].
    Hu B; Tian X; Huang H; Jian A; Ouyang S; Yin W; Duan W; Yang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 35(9):958-63. PubMed ID: 20871161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of detection of antibodies to fetal and adult acetylcholine receptors in myasthenia gravis.
    Shi QG; Wang ZH; Ma XW; Zhang DQ; Yang CS; Shi FD; Yang L
    Neurosci Bull; 2012 Oct; 28(5):469-74. PubMed ID: 22961471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
    J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro synthesis of antibodies to acetylcholine receptor by Epstein-Barr virus-stimulated B-lymphocytes derived from patients with myasthenia gravis.
    Brenner T; Timore Y; Wirguin I; Abramsky O; Steinitz M
    J Neuroimmunol; 1989 Oct; 24(3):217-22. PubMed ID: 2553772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of C3 level with severity of generalized myasthenia gravis.
    Liu A; Lin H; Liu Y; Cao X; Wang X; Li Z
    Muscle Nerve; 2009 Nov; 40(5):801-8. PubMed ID: 19670317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of P2X7 receptor in peripheral blood mononuclear cells correlates with clinical severity and serum levels of Th17-related cytokines in patients with myasthenia gravis.
    Zhang Y; Zhang Y; Li H; Jia X; Zhang X; Xia Y; Wang Y; Fu L; Xiao C; Geng D
    Clin Neurol Neurosurg; 2017 Jun; 157():88-94. PubMed ID: 28458152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increase in circulating B cell-activating factor in childhood-onset ocular myasthenia gravis.
    Motobayashi M; Inaba Y; Nishimura T; Kobayashi N; Nakazawa Y; Koike K
    Pediatr Neurol; 2015 Apr; 52(4):404-9. PubMed ID: 25661289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.